Nonfunctioning pituitary adenomas (NFPA; gonadotroph derived), even not inducing hormonal hypersecretion, cause significant morbidity by compression neighboring structures. No effective and specific medical methods are available so far for treating these tumors. The pituitary homeobox 2 (PITX2) gene is a member of the bicoid-like homeobox transcription factor family, which is involved in the Wnt/Dvl/␤-catenin pathway. PITX2 is overexpressed in NFPA. PITX2 mutations are known to be responsible for Axenfield Rieger syndrome, a genetic disorder in which pituitary abnormalities have been detected. The R91P mutant identified in Axenfeld Rieger syndrome is a dominant-negative factor, which is able to block the expression of several pituitary genes activated by PITX2. To better understand the role of Pitx2 on gonadotroph tumorigenesis and to explore new approach for inhibiting tumoral growth, the R91P mutant was transferred via a lentiviral vector in tumoral gonadotroph cells of two kinds: the ␣T3-1 cell line and human adenoma cells. R91P mutant and small interfering RNA directed against Pitx2 both decreased the viability of ␣T3-1 cells via an apoptotic mechanism involving the activation of executioner caspase. Similar effects of the R91P mutant were observed on human gonadotroph cells in primary culture. Therefore, Pitx2 overexpression may play an antiapoptotic role during NFPA tumorigenesis. (Endocrinology 152: 3884 -3892, 2011) 
T he pituitary homeobox 2 (PITX2) gene (which is also called RIEG) is a member of the bicoid-like homeobox transcription factor family involved in the development of the anterior pituitary gland and other anterior structures (1) . During mice pituitary ontogenesis, PITX2 mRNA is highly expressed in the developing pituitary gland by e 9.5 (day during embryogenesis) (2) , and Pitx2 protein is detected by e 10.5 (3) and continues to be expressed in the adult pituitary, in higher levels in gonadotroph cells than in other pituitary lineages (1, 3, 4) . Pitx2 gene inactivation in mice induced a block of a series of differentiation and proliferation events of the anterior pituitary gland organogenesis (5, 6) . In Pitx2-deficient mice, gonadotroph-specific markers (LH␤, FSH␤, GnRH receptor) were undetectable, which showed that gonadotroph development is highly sensitive to PITX2 deficiency (7), whereas overexpression of PITX2 resulted in an increase in the LH␤ and FSH␤ markers (4) . PITX2 is rapidly induced by the Wnt/Dvl/␤-catenin pathway that stabilizes Pitx2 mRNA by reducing the destabilizing effects of adenylate/uridylate-rich elements binding proteins. In this process of activation, PITX2 contributes importantly to stabilizing its own transcript by modulating the cytoplasmic concentration of a stabilizing adenylate/uridylate-rich elements binding proteins as well as to controlling the turnover of other unstable transcripts (c-jun, cyclin D1, cyclin D2) (2) .
PITX2 gene mutations have been detected in patients with Axenfeld Rieger syndrome (ARS), a genetic disorder characterized by ocular anomalies, dental hypoplasia, and mild craniofacial dysmorphism as well as abnormal cardiac, limb, and pituitary development (8, 9) . The phenotype of mice with reduced PITX2 levels mimicks ARS (7, 10) . R91P (p. Arg91Pro) is one of the PITX2 mutants identified in ARS patients. We have established that this mutation leads to a dominant-negative factor that preserves DNA binding activity but blocks PITX2-activated promoters such as human PRL, human GH, and POU1F1 (the human ortholog of Pit-1) (11) .
Human pituitary adenomas account for about 10% of all intracranial tumors. Nonfunctioning pituitary adenomas (NFPA), which do not induce abnormally high levels of hormone secretion, account for about 30% of these tumors. NFPA are benignant but cause significant morbidity because they tend to compress neighboring structures. More than 80% of NFPA are thought to be of gonadotropic origin (12, 13) . Apart from neurosurgical removal, no specific treatment is available so far for tumors of this kind. Several lines of evidence have indicated that the Wnt/␤-catenin pathway may play an important role in pituitary tumorigenesis (14, 15) . An increase in the ␤-catenin nuclear levels has been detected in some human pituitary adenomas. In addition, a decrease in the Wnt inhibitor factor 1 protein level (15) and a high expression level of PITX2 and CYCLIN D1 genes have been found to occur in NFPA (14, 16) . In fact, it has been suggested that Pitx2 may be one of the genes involved in the process of carcinogenesis of several tumors (17) .
To further determine the role of PITX2 in NFPA tumorigenesis and suggest new approaches for inhibiting gonadotroph tumoral cell viability, it was proposed here to introduce the R91P dominant-negative mutant into gonadotroph tumoral cells via a lentiviral vector. R91P gene expression resulted in a decrease in ␣T3-1 cell viability, thanks to an apoptotic mechanism involving executioner caspase activation. Similar effects were obtained using small interfering RNA (siRNA) directed against Pitx2. Lenti-R91P also induced a decrease in human gonadotroph tumoral cell viability.
Materials and Methods

Construction and production of lentiviral vectors
Mouse Pitx2, which shows 90% identity with human PITX2, and the dominant-negative form of Pitx2, Arg91Pro (R91P) (11) , were inserted into the lentiviral vector plasmid pRRLT-PGK-gene-IRES-eGFP-WPRE-sin18 (18) . These vectors were named lenti-Pitx2 and lenti-R91P, respectively. The transgenes were placed under the control of the human phosphoglycerate kinase promoter (PGK) and monitored using internal ribosome entry site-enhanced green fluorescent protein (eGFP). A third lentiviral vector, pRRLT-PGK-eGFP-WPRE-sin18 containing eGFP under the control of PGK (lenti-eGFP) was used as the control vector (19, 20) .
Lentiviral particles were generated as previously described (20) using each lentiviral vector plasmid, the vesicular stomatitis virus-G-encoding plasmid pMDG, and the packaging plasmid pCMVdeltaR8.91 (PlasmidFactory, Bielefeld, Germany). The supernatants containing the lentiviral particles were collected 24 and 48 h after the transfection step and concentrated by centrifugation using ultrafiltration methods (vivaspin 20; Sartorius Stedim Biotech, Aubagne, France), aliquoted, and stored at Ϫ80 C (20) .
Titration of the three lentiviral vectors was performed on HeLaT cells (cervical cancer cells) as previously described (20) . The percentage of transduced cells was determined using fluorescence-activated cell-sorting methods (FACS; Becton Dickinson, San Jose, CA). Data were analyzed with the Cell Quest program (Becton Dickinson). The viral titer was calculated as previously described (21) . Titers of around 1 ϫ 10 7 to 10 8 infectious particles per milliliter were obtained. All the supernatants were devoid of replication-competent virus, as determined by performing the replication-competent retrovirus assay as required by the French Ministry of Health.
Cell cultures
␣T3-1 cells provided from a mouse gonadotroph cell line, kindly given by P. L. Mellon (Center for Molecular Medecine, University of California, San Diego, CA) (22) were grown in appropriate medium (23) . The study was also carried out on seven human NFPA (G1-G7). It was approved by the university's Ethics Committee and was undertaken after obtaining the informed consent of all the patients. These seven tumors were macroadenomas and, based on the immunocytochemical data, they were gonadotroph ( Table 1) . Fragments of NFPA were dissociated mechanically and enzymatically. To eliminate the contaminant fibroblast, antifibroblast MicroBeads (Anti-Fibroblast MicroBeads human; Miltenyi Biotec, France) were applied as described by the manufacturer. Adenoma cells were plated onto well dishes coated with extracellular matrix of bovine corneal epithelial cells (24) . Cells were grown in L-Valin-depleted appropriated medium [L-Valin was replaced by D-Valin to block fibroblast proliferation (25) ].
Cell infection
Viral infections were carried out, using various multiplicities of infection (MOI; from 5 to 20 MOI) in the medium supplemented with 8 g/ml of polybrene. Seventeen hours after the infection step, the medium was changed in both the infected and non infected wells. This point in the procedure was taken to be postinfection d 1. To determine the transduction efficiency of the lentiviral vectors, FACS analysis was performed. In all these experiments, the results obtained with lenti-R91P or lenti-Pitx2 infected cells were compared with those obtained with lentieGFP infected cells and noninfected cells.
Silent interfering RNA
The Two Silencer Select Predesigned siRNA was used to target endogenous Pitx2 in ␣T3-1 cells (s71669 and s71671; purchased from Applied Biosystems, Courtaboeuf, France). Twenty-four hours after plating the cells into 12-or 24-well plates (to obtain 30 -50% confluence at the transfection step), ␣T3-1 cells were transfected in triplicate with 100 nM per well of each siRNA using lipofectamine 2000 (Invitrogene, Cergy Pontoise, France). Nontransfected wells were incubated with lipofectamine, using the same procedure. To check the transfection efficiency, Silencer FAM-labeled negative control siRNA (named FAM control siRNA; Applied Biosystems) was used. Forty-eight hours after the transfection step, cells were treated with trypsin and collected in tubes containing 800 l of culture medium containing propidium iodide (0.5 g/ml; BD PharMingen, San Jose, CA) and run on a FACS apparatus. Silencer Select glyceraldehyde-3-phosphate dehydrogenase (GAPDH) siRNA (Applied Biosystems) was used as the control substance and named control GAPDH siRNA. Moreover, in cell cycle analysis, FAM control siRNA was also used.
To test the efficiency of Pitx2 siRNA on Pitx2 mRNA, Chinese hamster ovary (CHO) cells that do not endogenously express Pitx2 were used. These cells were stably transfected with pTarget-luc-Pitx2 (Stratagene, Massy, France) containing the luciferase reporter gene fused with the coding sequence of the Pitx2 gene. Pitx2 siRNA were transfected using the same procedure as above.
RNA extraction and real-time PCR
Mouse (m) Pitx2 mRNA expression was monitored by performing real-time PCR during the lentiviral infection and siRNA transfection experiments. Six days after the infection step or 48 h after the transfection step, total mRNA were extracted using the RNeasy microkit (QIAGEN, Courtaboeuf, France) and reverse transcribed into cDNA (25) . The mPitx2 mRNA was quantified using the sybr green assay (purchased from QIAGEN). This assay recognizes endogenous and transgene mPitx2 mRNA. To quantify human (h) PITX2 mRNA, the 5Ј exonuclease (Taq man) assay was used. The following primers and probes were designed to specifically recognize hPITX2: hPitx2 probe, 5Ј-cga cat gta ccc agg cta ttc cta caa caa ctg-3Ј; hPitx2S, 5Ј-ttc aat ggg ctc atg cag c-3Ј; and hPitx2R, 5Ј-gga tag gga ggc gga tgt aag-3Ј (Invitrogene). The mcMyc RNA was quantified using a sybr green assay (purchased from QIAGEN).
The mRNA levels measured in ␣T3-1 cells were normalized to the mouse ␤-actin mRNA levels (using the ␤-actin sybr green assay purchased from QIAGEN). The relative quantification was performed using the 2 -⌬⌬Ct method (26) . The mRNA levels present in human cells were normalized to the human ␤-glucuronidase (␤Gus) mRNA levels (27) . For quantifying hPITX2 and mPitx2 in these cells, mRNA standard curves were draw up using plasmid-␥ dilutions, checked by performing sequencing and linearized. The plasmid-␥ of ␤Gus was purchased from Ipsogene (Marseille, France). The results of hPITX2 and mPitx2 quantification in NFPA were expressed as copy of gene per copy of ␤Gus ratios.
Western blotting
The levels of expression of PITX2 and R91P mutant were checked by performing Western blotting 6 d after the infection with 5 MOI lenti-Pitx2 or 5 MOI lenti-R91P as previously described (28) . Total denatured proteins (50 g) were separated on 12% SDS-PAGE gels and transferred to polyvinyl difluoride membranes (PerkinElmer, Courtaboeuf, France). Immunodetection of PITX2 was performed using a Pitx2-specific antibody (1:100) generously provided by Jeffrey C. Murray (Department of Pediatrics, University of Iowa, Iowa City, IA) (29) and using a bovine antirabbit IgG coupled to peroxidase as the secondary antibody (1:5000; Tebu-Bio Sa, Le Perray en Yvelines, France). Blots were developed with a chemiluminescent detection reagent (Immobilon Western chemiluminescent horseradish peroxidase substrate; Millipore, Molsheim, France). The intensity of the bands on the films was quantified using a densitometric system of analysis, the National Institutes of Health Image program, version 1.59 (Agfa Arcus II scanner; Agfa-Gevaert N.V., Mostel, Belgium), in which the background intensities were subtracted. The values given below are the means obtained after quantifying the specific bands, expressed as arbitrary OD units.
Cell viability
Cell viability was determined using an indirect method of estimating the number of viable cells, based on a luminescent cell viability assay (CellTiter-Glo; Promega Corp., Charbonnieres- 
Cell death analysis
The cell cycle distribution was analyzed using flow cytometry methods in lentiviral infection and in siRNA transfection experiments (25) . DNA cell distribution histograms were analyzed using the CellQuest Pro software program (Becton Dickinson). Ten thousand events were acquired for each analysis. Each experimental condition was assayed in triplicate.
To determine the mechanism involved in cell death, DNA fragmentation was analyzed on ␣T3-1 and human tumoral gonadotroph cells by performing terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) using the ApopTag Red in situ apoptosis detection kit (Chemicon International Inc., Temecula, CA). Each experimental condition was assayed in triplicate. Apoptotic cells were then viewed and scored manually with a Leica/Leitz (Darmstadt, Germany) DMRB microscope using a PL fluotar ϫ100 objective. The percentage of TUNELpositive cells was evaluated on the basis of more than 3,000 counted cells in 70 -120 successive fields.
Detection of caspase activity
The executioner caspase activities were measured in infection as well as in siRNA transfection experiments using the CaspaseGlo 3/7 assay (Promega) containing the substrate tetrapeptide sequence DEVD, which is specific to caspase-3 and -7. Each experimental condition was assayed in triplicate wells. Caspase activity was normalized to the cell number determined by performing the Celltiter-Glo assay (Promega). To confirm the involvement of caspase, caspase-3 and -7 inhibitor [DEVD-CHO (100 M) Calbiochem, Nottingham, UK] was added on wells infected and noninfected. The number of cells was determined using a luminescent cell viability assay after 9 d (Celltiter-Glo. Promega).
Statistical analysis
The results obtained are presented here as means Ϯ SEM. The statistical significance was determined by performing the Wilcoxon nonparametric test between paired groups and the MannWhitney nonparametric test between unpaired groups. Differences were taken to be statistically significant at a probability level of P Ͻ 0.05.
Results
Lentiviral transduction efficiency and Pitx2 and R91P mRNA and protein expression in ␣T3-1
Six days after infection with lenti-eGFP, lenti-Pitx2, or lenti-R91P at 5 MOI, the mean percentage of ␣T3-1 expressing eGFP was 71.5 Ϯ 6.5, 61.7 Ϯ 8, and 63.6 Ϯ 8%, respectively. In noninfected cells, no eGFP-expressing cells were detected (data not shown). Endogenous Pitx2 mRNA expression was detected in the ␣T3-1 cell line and did not differ significantly between lenti-eGFP-infected cells and noninfected cells (mean relative Pitx2 mRNA levels: 1.2 Ϯ 0.77 and 1.3 Ϯ 0.89, respectively). The Pitx2 mRNA levels increased approximately 4.6-fold after infection with lenti-Pitx2 and 7.8-fold after infection with lenti-R91P (Fig. 1 A) . This difference between the levels of Pitx2 mRNA expression after lenti-Pitx2 and lenti-R91P infection was not statistically significant. On Western blot, in noninfected cells (Fig. 1B, line 1) , one band was detected at around 32 kDa, corresponding to endogenous PITX2 protein. In lenti-Pitx2 infected cells (Fig.  1B, line 2) and lenti-R91P infected cells (Fig. 1B, line 3) , only one band was detected at the same molecular weight. Quantification of the bands normalized to the level of ␤-actin protein showed that PITX2 protein expression increased considerably (ϳ4.5 fold) after infection by lenti-Pitx2 or lenti-R91P (Fig. 1C) . These data showed that these lentiviral vectors efficiently transduced the ␣T3-1 cell line in vitro and strongly induced the expression of the respective transgene: Pitx2 wild-type and R91P mutant.
To validate this model, the impact of wild-type and dominant negative transgenic Pitx2 was analyzed on usual Pitx2 target as cmyc (30) . In ␣T3-1 cells, the transfer of wild-type Pitx2 increased the cMyc mRNA levels (ϩ197 Ϯ 5%), whereas the R91P mutant decreased it (Ϫ56 Ϯ 7%, Fig. 1D ).
R91P induced a decrease in ␣T3-1 cell viability
The number of cells present in wells infected with lenti-eGFP was similar to that observed in noninfected wells ( Fig.  2A) . In wells infected with lenti-R91P, the number of cells decreased significantly in comparison with lenti-eGFPinfected wells. The mean rates of decrease were 16.5 Ϯ 3.35, 42 Ϯ 7, and 57 Ϯ 10% 3, 6, and 9 d after infection, respectively ( Fig. 2A) . These data clearly show that lenti-R91P has negative effects on ␣T3-1 cell viability. Lenti-Pitx2 also induced a slight decrease in cell viability, which reached significance level only after 9 d of infection (mean rate of decrease in the number of lenti-Pitx2 cells vs. lentieGFP cells: 18.1 Ϯ 5%, P Ͻ 0.02). All these results obtained using an indirect method (CellTiter-Glo;, Promega) were confirmed by performing a direct cell count (data not shown).
␣T3-1 cell death induced by R91P involved an apoptotic mechanism
To determine the pathway whereby R91P induced a decrease in the number of cells, the cell cycle was analyzed using flow cytometry methods. In lenti-R91P-infected cells, the proportion of the cells in the subdiploid sub-G1 phase (corresponding to cell death) increased significantly in comparison with the noninfected cells (Fig. 2B) . A little but significant decrease in the proportion of lenti-R91P-infected cells was observed in the G0/G1 phase, whereas the proportion of cells in the S or G2-M phases did not differ significantly. The proportions of the other three categories of cells (lenti-eGFP, lenti-Pitx2, noninfected cells) were similar in each phase of the cell cycle. These data suggest that lenti-R91P transfer into ␣T3-1 cells decreased the number of cells by promoting apoptotic cell death.
To confirm the apoptotic effects of R91P, DNA fragmentation was investigated by performing the TUNEL assay. The number of apoptotic cells was found to be significantly higher in cells infected with lenti-R91P (mean number of apoptotic events 8.48 Ϯ 0.80) than in lentieGFP-infected or lenti-Pitx2-infected cells (mean number of apoptotic events 3.98 Ϯ 0.60 and 3.40 Ϯ 0.70, respectively, Fig. 2C, left panels) . To determine the apoptotic mechanism involved, the activity of executioner caspases was measured. Lenti-R91P infection significantly increased the basal caspase activity detected in lenti-eGFP cells (rate of increase: 38 Ϯ 8.5%, P Ͻ 0.0001), whereas no significant effects were observed after lenti-Pitx2 infection (Fig. 2C, right panels) . In addition, the decrease in the number of cells observed in response to lenti-R91P (decrease of 23.5 Ϯ 2.0% vs. lenti-eGFP cells) was reversed by the addition of caspase-3 and -7 inhibitor DEVD-CHO (decrease of 9.0 Ϯ 1.4% vs. lenti-eGFP cells, Fig. 2D ).
These data show that lenti-R91P transfer in ␣T3-1 cells induced cell apoptosis by promoting executioner caspase activity.
Effects of Pitx2 siRNA on the ␣T3-1 gonadotroph cell line
To confirm the decrease in cell viability induced by the Pitx2 protein inactivation and that this decrease involved apoptotic mechanism, two siRNA directed against Pitx2 (which are called siRNA 69 and siRNA 71 here) were used. Using a FAM control siRNA, the proportion of transfected cells was found to be approximately 56.8 Ϯ 7% 48 h after the transfection step. Into CHO cells expressing a transgenic Pitx2, the rates of decrease in Pitx2 mRNA recorded in response to the two siRNA were 86.4 and 72.1%, respectively. In ␣T3-1 cells, both siRNA decreased the endogenous levels of Pitx2 mRNA expression by 53.8 Ϯ 10% (mean relative Pitx2 mRNA level under siRNA: 0.71 Ϯ 0.26 vs. in nontransfected cells 1.32 Ϯ 0.19) and decreased the endogenous levels of Pitx2 protein expression by 60% (data not shown). With each Pitx2 siRNA, a decrease in the number of cells was observed, whereas no effect on cell viability was found in response to control GAPDH siRNA (Fig. 3A) and FAM control siRNA (data not shown) in comparison with nontransfected cells. The mean percentage decrease in the number of transfected vs. nontransfected cells was 31.0 Ϯ 21 and 29.5 Ϯ 16% with siRNA 69 and 71, respectively (Fig. 3A) .
The cell cycle analysis showed that the proportions of the cells in the sub-G1 phase increased significantly in response to each Pitx2 siRNA in comparison with both GAPDH and FAM control siRNA and with nontransfected cells (Fig. 3B) , whereas the proportion of the cells in the G0/G1 phase decreased, without reaching the significance threshold. No significant differences were observed in any of the phases in the cell cycle between both control siRNA transfected cells and nontransfected cells. In addition, 48 h after transfection with Pitx2 siRNA, an increase in executioner caspase activity was observed in comparison with the levels detected in nontransfected and control Fig. 3C ).
Effects of lenti-R91P on human NFPA
To test whether these data obtained on murine gonadotroph cell line might be also relevant to the human tumors, the effects of R91P mutant transfer were tested on primary culture of seven human gonadotroph tumors. Lentiviral vectors have been found to efficiently transduce human pituitary tumoral cells in primary cultures, giving about 75 Ϯ 5% transduced cells (20) . Endogenous hPITX2 mRNA expression was found in all the tumors tested, and these levels were not affected by infection with any of the present lentiviral vectors [mean hPITX2 mRNA level 33 (5-129) copy/copy ␤Gus]. Transgenic mPitx2 mRNA levels were strongly expressed after infection with lenti-Pitx2 and lenti-R91P [mean mPitx2 mRNA level 319.8 (103-1107) and 304.0 (50 -898) copy/copy ␤Gus, respectively] (Fig. 4A) . A significant negative effect of R91P on cell viability was observed in the five tumors tested 9 d after infection at 10 MOI (Ϫ29 Ϯ 5, Ϫ53 Ϯ 2, Ϫ34 Ϯ 10, Ϫ14 Ϯ 5, and Ϫ38 Ϯ 6% for G1, G2, G3, G4, and G7, respectively, P Ͻ 0.02 vs. lenti-eGFP cells, Fig. 4B ). Moreover, DNA fragmentation was investigated by performing the TUNEL assay on primary culture of three NFPA, 5 d after infection at 10 MOI. The number of apoptotic cells was found to be significantly larger in lenti-R91P infected cells (mean number of apoptotic events: 15.1 Ϯ 3.31) than in lenti-eGFP-infected or lenti-Pitx2-infected cells (mean number of apoptotic events: 6.1 Ϯ 2.29 and 7.8 Ϯ 2.87, P Ͻ 0.0001, vs. lenti-eGFP cells, Fig. 4C ).
Discussion
No completely satisfactory methods are available so far for treating human NFPA. These tumors not inducing hormonal hypersecretion are associated with symptoms resulting from the invasion or compression of the surrounding structures, which in most cases makes it impossible to perform complete neurosurgical removal in the later stages of the disease. Dopamine and somatostatin analogs are rarely efficient means of dealing with tumors of this kind. In a recent reassessment of dopamine agonist efficacy in NFPA, a tumoral reduction was reported to occur in only 27.6% of these tumors (31) . Radiotherapy is often used after tumor surgery, but this treatment takes a long time to be effective and there are complications, the most common of which is hypopituitarism (31) .
In this context, gene therapy may be a potentially useful alternative method of targeted treatment for NFPA. The dominant negative PITX2 mutant R91P was thought to be a good candidate gene for the following reasons: 1) PITX2 is highly expressed in NFPA (16); 2) this protein is induced by the Wnt/Dvl/␤catenin pathway, which is involved in pituitary tumorigenesis (14) ; 3) during pituitary development, gonadotroph cells are the most sensitive cells to decreased levels of Pitx2 expression (7); 4) the R91P mutant is involved in human ARS and its dominant-negative function has been established (11) .
In the present study, we established that the R91P dominant-negative mutant strongly decreases the viability of mouse ␣T3-1 gonadotroph tumoral cells and that of human tumor cells in vitro. The cell cycle analysis of ␣T3-1 cells showed that, under our experimental conditions, the decrease in cell viability of lenti-R91P-infected cells involved a process of cell death due to an increase in the   FIG. 4 . Lenti-R91P infection decreased the viability of human gonadotroph adenoma cells in vitro by an apoptotic mechanism. A, hPitx2 and mPitx2 mRNA expression before and after infection by lentieGFP, lenti-Pitx2, and lenti-R91P of seven human gonadotroph adenomas. Results are expressed in Pitx2 copies per ␤Gus copies. NA, Not available. B, Cell viability was monitored by performing luminescent cell viability assays 9 d after the infection step at 10 MOI of five NFPA (G1, G2, G3, G4, G7). Results are expressed as rates of cell viability vs. those of noninfected cells. *, P Ͻ 0.02 vs. lenti-eGFP infected cells. C, DNA fragmentation analysis based on a TUNEL assay 5 d after infection step at 10 MOI of three NFPA (G5, G6, G7). Results are expressed as the number of positive events per field. **, P Ͻ 0.0001 vs. lenti-eGFP cells.
sub-G1 population rather than a decrease in cell proliferation. Lin et al. (5) were the first to describe the occurrence of a decrease in the number of pituitary cells in Pitx2 Ϫ/Ϫ mice. In a study based on the use of 5-bromo-2Ј-deoxyuridine incorporation methods, Kioussi et al. (6) suggested that the pituitary hypoplasia observed in these mice may have been due to a decrease in the rate of cell proliferation. However, in the latter two studies, the mechanism responsible for the decrease in the number of cells was not consistently analyzed. In the present study, the apoptotic effects of Pitx2 inactivation observed in response to the R91P mutant were confirmed by the results of siRNA experiments because Pitx2 siRNA also induced apoptotic cell death. The present results are in agreement with those obtained by Charles et al. (4) , which showed that apoptotic cell death contributes importantly to the process of pituitary hypoplasia observed in Pitx2 null mice during their development. Moreover, we established that the cell death resulting from the Pitx2 inactivation, induced by dominant-negative R91P or siRNA, resulted from executioner caspase activation. The mechanism by which Pitx2 inactivation is involved in caspase activity has yet to be determined. The results obtained here on human pituitary tumors were promising.
When wild-type PITX2 was overexpressed, we also observed a slight but significant decrease in ␣T3-1 cell viability but only in the long term. In fact, the activity of Pitx2 is sensitive to gene dosage (7) . In mice, up-regulation and inactivation of Pitx2 induce similar ocular disorders (32) . Pitx2 also inhibits cell proliferation in HeLa cells that do not express endogenous Pitx2 (33) . However, in our experiments the decrease in cell viability was distinctly smaller in response to Pitx2 overexpression than to R91P, and this decrease was not associated with any changes in the basal caspase activities, the cell cycle, and apoptotic events. The exact molecular mechanisms involved in the cell death induced by Pitx2 overexpression still remains to be elucidated.
Apoptosis is an important process in the case of neoplastic lesions, whereas these events are fairly rare in human pituitary tumors. In addition the apoptotic labeling index has been found to be lower in NFPA than in functioning human pituitary adenomas (34) . Therefore, the high expression of the PITX2 gene observed in gonadotroph adenomas (16) may play a role in pituitary tumorigenesis via an antiapoptotic effect. The results of this study suggest that dominant-negative PITX2 mutants or Pitx2 siRNA may provide useful new tools for developing targeted strategies for treating tumors in which PITX2 is overexpressed. Animal model of spontaneous pituitary adenomas will be essential for evaluating the lenti-R91P effect in vivo for a potential human application in gene therapy stategy.
